🌸 Genitourinary Syndrome of Menopause Local Estrogen Simulator

Vaginal and Urinary Tissue Depend on Estrogen

Estrogen maintains vaginal and urinary tract tissue integrity.

• Vagina, vulva: Affected tissues (and lower urinary tract)
• ER-α/β: Key receptor (estrogen receptor subtypes)
• ~50%: Prevalence in menopause (placeholder estimate)
• Perimenopause+: Onset (placeholder timing)

Estrogen and tissue maintenance

Placeholder: estrogen supports epithelial thickness and blood flow.

Tissue Thinning and Dryness With Estrogen Decline

Declining estrogen causes thinning, dryness, and irritation.

• ↓: Epithelial thickness (placeholder decline)
• Dryness, pain: Common symptoms (placeholder list)
• Urgency, UTIs: Urinary symptoms (placeholder list)
• ↑ pH: pH shift (placeholder change)

Atrophic tissue changes

Placeholder: thinning epithelium and reduced lubrication occur.

Low-Dose Local Estrogen Therapy Application

Local estrogen is applied directly to affected tissue.

• Cream, tablet, ring: Formulations (placeholder options)
• Low-dose: Typical dose (placeholder value)
• Vaginal: Application site (placeholder detail)
• ~2 weeks: Induction phase (placeholder schedule)

Local delivery method

Placeholder: local application targets tissue directly, minimizing dose.

Local Dosing Limits Systemic Estrogen Exposure

Local therapy keeps systemic estrogen levels very low.

• Minimal: Systemic absorption (placeholder comparison)
• Much lower: vs. systemic HRT (placeholder comparison)
• ~unchanged: Serum estradiol (placeholder value)
• Favorable: Safety profile (placeholder note)

Systemic exposure advantage

Placeholder: minimal absorption reduces systemic hormone exposure risk.

Symptom Improvement Across the Treatment Course

Symptoms improve gradually over weeks of local therapy.

• Weeks: Time to relief (placeholder timeline)
• Gradual: Dryness improvement (placeholder trend)
• Gradual: Urinary symptom relief (placeholder trend)
• Ongoing: Maintenance dosing (placeholder note)

Course outcome

Placeholder: sustained local therapy yields lasting symptom relief.

Placeholder key insight: consistent local dosing improves outcomes.